

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 7.01154044 |
| 2 | ATP synthesis coupled proton transport (GO:0015986) | 6.30035127 |
| 3 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 6.30035127 |
| 4 | establishment of protein localization to mitochondrial membrane (GO:0090151) | 5.88373710 |
| 5 | proteasome assembly (GO:0043248) | 5.10109689 |
| 6 | sequestering of actin monomers (GO:0042989) | 5.09605664 |
| 7 | protein complex biogenesis (GO:0070271) | 4.94029361 |
| 8 | mitochondrial respiratory chain complex assembly (GO:0033108) | 4.50940240 |
| 9 | mitochondrial respiratory chain complex I assembly (GO:0032981) | 4.47744242 |
| 10 | NADH dehydrogenase complex assembly (GO:0010257) | 4.47744242 |
| 11 | mitochondrial respiratory chain complex I biogenesis (GO:0097031) | 4.47744242 |
| 12 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 4.43871896 |
| 13 | respiratory electron transport chain (GO:0022904) | 4.37472730 |
| 14 | electron transport chain (GO:0022900) | 4.28456590 |
| 15 | protein neddylation (GO:0045116) | 4.22910233 |
| 16 | protein-cofactor linkage (GO:0018065) | 4.13658154 |
| 17 | dopaminergic neuron differentiation (GO:0071542) | 4.12899885 |
| 18 | DNA damage response, detection of DNA damage (GO:0042769) | 4.12728979 |
| 19 | respiratory chain complex IV assembly (GO:0008535) | 3.83708056 |
| 20 | protein targeting to mitochondrion (GO:0006626) | 3.78231484 |
| 21 | chaperone-mediated protein transport (GO:0072321) | 3.77496694 |
| 22 | regulation of mitochondrial translation (GO:0070129) | 3.74603260 |
| 23 | protein localization to mitochondrion (GO:0070585) | 3.72419767 |
| 24 | establishment of protein localization to mitochondrion (GO:0072655) | 3.70379895 |
| 25 | rRNA modification (GO:0000154) | 3.61107869 |
| 26 | tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388) | 3.59835841 |
| 27 | RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394) | 3.59835841 |
| 28 | cytochrome complex assembly (GO:0017004) | 3.58218159 |
| 29 | GTP biosynthetic process (GO:0006183) | 3.58050608 |
| 30 | purine nucleoside triphosphate biosynthetic process (GO:0009145) | 3.52726725 |
| 31 | exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay | 3.51511710 |
| 32 | nuclear-transcribed mRNA catabolic process, exonucleolytic (GO:0000291) | 3.50287216 |
| 33 | purine ribonucleoside triphosphate biosynthetic process (GO:0009206) | 3.48800278 |
| 34 | inner mitochondrial membrane organization (GO:0007007) | 3.48771994 |
| 35 | regulation of glucokinase activity (GO:0033131) | 3.48135528 |
| 36 | regulation of hexokinase activity (GO:1903299) | 3.48135528 |
| 37 | ATP biosynthetic process (GO:0006754) | 3.45879121 |
| 38 | hydrogen ion transmembrane transport (GO:1902600) | 3.43394653 |
| 39 | water-soluble vitamin biosynthetic process (GO:0042364) | 3.38670098 |
| 40 | pseudouridine synthesis (GO:0001522) | 3.33520744 |
| 41 | ubiquinone biosynthetic process (GO:0006744) | 3.20296654 |
| 42 | pyrimidine deoxyribonucleotide catabolic process (GO:0009223) | 3.13317997 |
| 43 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 3.11953721 |
| 44 | proton transport (GO:0015992) | 3.11510988 |
| 45 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051437) | 3.09759574 |
| 46 | intracellular protein transmembrane import (GO:0044743) | 3.06667013 |
| 47 | indolalkylamine metabolic process (GO:0006586) | 3.05532081 |
| 48 | hydrogen transport (GO:0006818) | 3.05023220 |
| 49 | hindbrain development (GO:0030902) | 3.02915051 |
| 50 | ubiquinone metabolic process (GO:0006743) | 3.02329803 |
| 51 | ribonucleoside triphosphate biosynthetic process (GO:0009201) | 3.00104471 |
| 52 | positive regulation of prostaglandin secretion (GO:0032308) | 2.98626655 |
| 53 | mitochondrial transport (GO:0006839) | 2.98137310 |
| 54 | neuron fate specification (GO:0048665) | 2.97376142 |
| 55 | termination of RNA polymerase III transcription (GO:0006386) | 2.96256391 |
| 56 | transcription elongation from RNA polymerase III promoter (GO:0006385) | 2.96256391 |
| 57 | rRNA methylation (GO:0031167) | 2.94179247 |
| 58 | tRNA processing (GO:0008033) | 2.92451769 |
| 59 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051439) | 2.89204461 |
| 60 | regulation of cellular amino acid metabolic process (GO:0006521) | 2.88328593 |
| 61 | dopamine biosynthetic process (GO:0042416) | 2.87704669 |
| 62 | substrate-independent telencephalic tangential interneuron migration (GO:0021843) | 2.85392662 |
| 63 | substrate-independent telencephalic tangential migration (GO:0021826) | 2.85392662 |
| 64 | behavioral response to nicotine (GO:0035095) | 2.84917512 |
| 65 | UTP biosynthetic process (GO:0006228) | 2.84127561 |
| 66 | nucleoside triphosphate biosynthetic process (GO:0009142) | 2.83658049 |
| 67 | cellular component biogenesis (GO:0044085) | 2.82819082 |
| 68 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:00 | 2.82705407 |
| 69 | rRNA processing (GO:0006364) | 2.81172997 |
| 70 | negative regulation of ubiquitin-protein transferase activity (GO:0051444) | 2.80317009 |
| 71 | negative regulation of ligase activity (GO:0051352) | 2.80317009 |
| 72 | ribosomal large subunit biogenesis (GO:0042273) | 2.80191940 |
| 73 | rRNA metabolic process (GO:0016072) | 2.78772880 |
| 74 | transcription from mitochondrial promoter (GO:0006390) | 2.77882179 |
| 75 | serotonin metabolic process (GO:0042428) | 2.76151120 |
| 76 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0 | 2.75651668 |
| 77 | guanosine-containing compound biosynthetic process (GO:1901070) | 2.75213978 |
| 78 | translation (GO:0006412) | 2.75189783 |
| 79 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 2.74539966 |
| 80 | signal transduction involved in mitotic DNA damage checkpoint (GO:1902402) | 2.72533703 |
| 81 | signal transduction involved in mitotic cell cycle checkpoint (GO:0072413) | 2.72533703 |
| 82 | signal transduction involved in mitotic DNA integrity checkpoint (GO:1902403) | 2.72533703 |
| 83 | intracellular signal transduction involved in G1 DNA damage checkpoint (GO:1902400) | 2.72128467 |
| 84 | signal transduction involved in mitotic G1 DNA damage checkpoint (GO:0072431) | 2.72128467 |
| 85 | pyrimidine deoxyribonucleotide metabolic process (GO:0009219) | 2.71734885 |
| 86 | signal transduction involved in DNA integrity checkpoint (GO:0072401) | 2.71451248 |
| 87 | signal transduction involved in DNA damage checkpoint (GO:0072422) | 2.71451248 |
| 88 | signal transduction involved in cell cycle checkpoint (GO:0072395) | 2.69330101 |
| 89 | cotranslational protein targeting to membrane (GO:0006613) | 2.67648404 |
| 90 | DNA replication checkpoint (GO:0000076) | 2.66551383 |
| 91 | adenosine metabolic process (GO:0046085) | 2.65859303 |
| 92 | positive regulation of ubiquitin-protein transferase activity (GO:0051443) | 2.64658642 |
| 93 | tRNA metabolic process (GO:0006399) | 2.64266456 |
| 94 | viral transcription (GO:0019083) | 2.63798458 |
| 95 | nucleoside diphosphate phosphorylation (GO:0006165) | 2.62724114 |
| 96 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 2.62493446 |
| 97 | translational termination (GO:0006415) | 2.62243437 |
| 98 | protein K6-linked ubiquitination (GO:0085020) | 2.61474470 |
| 99 | quinone biosynthetic process (GO:1901663) | 2.61165161 |
| 100 | protein targeting to ER (GO:0045047) | 2.60248818 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 4.88321654 |
| 2 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 4.09759270 |
| 3 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 3.92561153 |
| 4 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 3.91115670 |
| 5 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 3.59696890 |
| 6 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 3.39108266 |
| 7 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 3.30830223 |
| 8 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 3.16234417 |
| 9 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 3.10375661 |
| 10 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 2.89307294 |
| 11 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 2.86341422 |
| 12 | ELK1_19687146_ChIP-ChIP_HELA_Human | 2.72350370 |
| 13 | VDR_23849224_ChIP-Seq_CD4+_Human | 2.69953252 |
| 14 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 2.69695877 |
| 15 | VDR_22108803_ChIP-Seq_LS180_Human | 2.59743144 |
| 16 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 2.59645965 |
| 17 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 2.57531077 |
| 18 | ZNF274_21170338_ChIP-Seq_K562_Hela | 2.32066592 |
| 19 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 2.18787811 |
| 20 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 2.15971351 |
| 21 | IGF1R_20145208_ChIP-Seq_DFB_Human | 2.12135761 |
| 22 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 2.09759272 |
| 23 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 2.08548159 |
| 24 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 2.05641748 |
| 25 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 2.00441982 |
| 26 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.95820662 |
| 27 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.92295565 |
| 28 | MYC_18940864_ChIP-ChIP_HL60_Human | 1.90202330 |
| 29 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.81827047 |
| 30 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.78956852 |
| 31 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.74203788 |
| 32 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.71786224 |
| 33 | E2F7_22180533_ChIP-Seq_HELA_Human | 1.69537330 |
| 34 | TTF2_22483619_ChIP-Seq_HELA_Human | 1.67279272 |
| 35 | EZH2_22144423_ChIP-Seq_EOC_Human | 1.65936484 |
| 36 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.61988853 |
| 37 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 1.61935463 |
| 38 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.60913114 |
| 39 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.60745863 |
| 40 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 1.59987593 |
| 41 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.59879209 |
| 42 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.59840200 |
| 43 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.56935409 |
| 44 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.55254811 |
| 45 | SOX2_16153702_ChIP-ChIP_HESCs_Human | 1.53165399 |
| 46 | EWS_26573619_Chip-Seq_HEK293_Human | 1.52616660 |
| 47 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.48165617 |
| 48 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.45520471 |
| 49 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.43251526 |
| 50 | POU5F1_16153702_ChIP-ChIP_HESCs_Human | 1.39409681 |
| 51 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.38638839 |
| 52 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.37199505 |
| 53 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 1.36753708 |
| 54 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.36423635 |
| 55 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.35269791 |
| 56 | POU5F1_18358816_ChIP-ChIP_MESCs_Mouse | 1.30665981 |
| 57 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.28097140 |
| 58 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.25571641 |
| 59 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.24595515 |
| 60 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.24594498 |
| 61 | YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.21480031 |
| 62 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.20915075 |
| 63 | FUS_26573619_Chip-Seq_HEK293_Human | 1.20096373 |
| 64 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.17851719 |
| 65 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.15042810 |
| 66 | TP53_22573176_ChIP-Seq_HFKS_Human | 1.11395058 |
| 67 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.10675100 |
| 68 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.09407541 |
| 69 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.08256805 |
| 70 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.07840051 |
| 71 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.06777095 |
| 72 | NANOG_16153702_ChIP-ChIP_HESCs_Human | 1.06368222 |
| 73 | PAX6_23342162_ChIP-ChIP_BETA-FORBRAIN-LENS_Mouse | 1.04426295 |
| 74 | ASH2L_23239880_ChIP-Seq_MESCs_Mouse | 1.03236048 |
| 75 | RCOR1_19997604_ChIP-ChIP_NEURONS_Mouse | 1.03191685 |
| 76 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.01774342 |
| 77 | IRF1_19129219_ChIP-ChIP_H3396_Human | 0.98919502 |
| 78 | CIITA_25753668_ChIP-Seq_RAJI_Human | 0.97952365 |
| 79 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 0.97138040 |
| 80 | HTT_18923047_ChIP-ChIP_STHdh_Human | 0.95948808 |
| 81 | P300_19829295_ChIP-Seq_ESCs_Human | 0.94127062 |
| 82 | ELK1_22589737_ChIP-Seq_MCF10A_Human | 0.93517976 |
| 83 | HOXD13_18407260_ChIP-ChIP_DEVELOPING-LIMBS_Mouse | 0.93231776 |
| 84 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 0.92867181 |
| 85 | KDM5A_27292631_Chip-Seq_BREAST_Human | 0.92624810 |
| 86 | TP63_19390658_ChIP-ChIP_HaCaT_Human | 0.90495782 |
| 87 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 0.90213122 |
| 88 | FOXA1_27270436_Chip-Seq_PROSTATE_Human | 0.88844489 |
| 89 | FOXA1_25329375_ChIP-Seq_VCAP_Human | 0.88844489 |
| 90 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 0.86840115 |
| 91 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 0.85722418 |
| 92 | CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 0.82693105 |
| 93 | FOXP2_21765815_ChIP-ChIP_NEURO2A_Mouse | 0.82642534 |
| 94 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.81446802 |
| 95 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 0.81446802 |
| 96 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 0.81222799 |
| 97 | SALL4_22934838_ChIP-ChIP_CD34+_Human | 0.78167606 |
| 98 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 0.77871728 |
| 99 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.76904945 |
| 100 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 0.76686113 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0000569_abnormal_digit_pigmentation | 5.92282324 |
| 2 | MP0001529_abnormal_vocalization | 3.83905153 |
| 3 | MP0002102_abnormal_ear_morphology | 3.50606575 |
| 4 | MP0000566_synostosis | 3.31275352 |
| 5 | MP0006072_abnormal_retinal_apoptosis | 3.10302955 |
| 6 | MP0003011_delayed_dark_adaptation | 2.78752111 |
| 7 | MP0005645_abnormal_hypothalamus_physiol | 2.76685333 |
| 8 | MP0003806_abnormal_nucleotide_metabolis | 2.55403885 |
| 9 | MP0001905_abnormal_dopamine_level | 2.36358759 |
| 10 | MP0003880_abnormal_central_pattern | 2.30335607 |
| 11 | MP0003195_calcinosis | 2.13282600 |
| 12 | MP0006276_abnormal_autonomic_nervous | 2.04590321 |
| 13 | MP0004742_abnormal_vestibular_system | 2.02568272 |
| 14 | MP0002909_abnormal_adrenal_gland | 1.88843468 |
| 15 | MP0000372_irregular_coat_pigmentation | 1.88493357 |
| 16 | MP0003283_abnormal_digestive_organ | 1.82600658 |
| 17 | MP0002938_white_spotting | 1.82418012 |
| 18 | MP0002163_abnormal_gland_morphology | 1.80340393 |
| 19 | MP0006292_abnormal_olfactory_placode | 1.78084859 |
| 20 | MP0003121_genomic_imprinting | 1.77073671 |
| 21 | MP0010094_abnormal_chromosome_stability | 1.77024663 |
| 22 | MP0006035_abnormal_mitochondrial_morpho | 1.65015966 |
| 23 | MP0009379_abnormal_foot_pigmentation | 1.64461670 |
| 24 | MP0002822_catalepsy | 1.63718974 |
| 25 | MP0008872_abnormal_physiological_respon | 1.63105651 |
| 26 | MP0002837_dystrophic_cardiac_calcinosis | 1.57392255 |
| 27 | MP0008058_abnormal_DNA_repair | 1.56325951 |
| 28 | MP0003122_maternal_imprinting | 1.54999650 |
| 29 | MP0001346_abnormal_lacrimal_gland | 1.53032160 |
| 30 | MP0008789_abnormal_olfactory_epithelium | 1.49527781 |
| 31 | MP0003186_abnormal_redox_activity | 1.46529871 |
| 32 | MP0008877_abnormal_DNA_methylation | 1.46242422 |
| 33 | MP0003693_abnormal_embryo_hatching | 1.45676892 |
| 34 | MP0005253_abnormal_eye_physiology | 1.43065611 |
| 35 | MP0000631_abnormal_neuroendocrine_gland | 1.39810020 |
| 36 | MP0003937_abnormal_limbs/digits/tail_de | 1.39454154 |
| 37 | MP0006036_abnormal_mitochondrial_physio | 1.39219174 |
| 38 | MP0004133_heterotaxia | 1.38753400 |
| 39 | MP0003123_paternal_imprinting | 1.35530517 |
| 40 | MP0009697_abnormal_copulation | 1.34639985 |
| 41 | MP0003787_abnormal_imprinting | 1.34427444 |
| 42 | MP0003315_abnormal_perineum_morphology | 1.32025134 |
| 43 | MP0003077_abnormal_cell_cycle | 1.30804733 |
| 44 | MP0005084_abnormal_gallbladder_morpholo | 1.28692892 |
| 45 | MP0002160_abnormal_reproductive_system | 1.25592937 |
| 46 | MP0005499_abnormal_olfactory_system | 1.20892898 |
| 47 | MP0005394_taste/olfaction_phenotype | 1.20892898 |
| 48 | MP0003646_muscle_fatigue | 1.19453872 |
| 49 | MP0003786_premature_aging | 1.19180868 |
| 50 | MP0005220_abnormal_exocrine_pancreas | 1.16779953 |
| 51 | MP0005379_endocrine/exocrine_gland_phen | 1.16503216 |
| 52 | MP0004924_abnormal_behavior | 1.14331390 |
| 53 | MP0005386_behavior/neurological_phenoty | 1.14331390 |
| 54 | MP0004885_abnormal_endolymph | 1.13016503 |
| 55 | MP0008995_early_reproductive_senescence | 1.09049771 |
| 56 | MP0004142_abnormal_muscle_tone | 1.08804492 |
| 57 | MP0005551_abnormal_eye_electrophysiolog | 1.07092968 |
| 58 | MP0005646_abnormal_pituitary_gland | 1.02452109 |
| 59 | MP0000778_abnormal_nervous_system | 1.01534722 |
| 60 | MP0002184_abnormal_innervation | 0.99774627 |
| 61 | MP0009745_abnormal_behavioral_response | 0.98022853 |
| 62 | MP0009046_muscle_twitch | 0.97689561 |
| 63 | MP0002751_abnormal_autonomic_nervous | 0.96903060 |
| 64 | MP0001944_abnormal_pancreas_morphology | 0.94305771 |
| 65 | MP0002272_abnormal_nervous_system | 0.91898744 |
| 66 | MP0002557_abnormal_social/conspecific_i | 0.91707516 |
| 67 | MP0000358_abnormal_cell_content/ | 0.90108996 |
| 68 | MP0001293_anophthalmia | 0.87632006 |
| 69 | MP0001324_abnormal_eye_pigmentation | 0.87589575 |
| 70 | MP0005187_abnormal_penis_morphology | 0.87511562 |
| 71 | MP0000049_abnormal_middle_ear | 0.87440816 |
| 72 | MP0001984_abnormal_olfaction | 0.86767744 |
| 73 | MP0004957_abnormal_blastocyst_morpholog | 0.86399724 |
| 74 | MP0002067_abnormal_sensory_capabilities | 0.84388294 |
| 75 | MP0002734_abnormal_mechanical_nocicepti | 0.83697540 |
| 76 | MP0005195_abnormal_posterior_eye | 0.83397764 |
| 77 | MP0002210_abnormal_sex_determination | 0.81820169 |
| 78 | MP0003890_abnormal_embryonic-extraembry | 0.80554293 |
| 79 | MP0000026_abnormal_inner_ear | 0.78722767 |
| 80 | MP0002693_abnormal_pancreas_physiology | 0.78587888 |
| 81 | MP0009250_abnormal_appendicular_skeleto | 0.77865138 |
| 82 | MP0002277_abnormal_respiratory_mucosa | 0.77577098 |
| 83 | MP0002752_abnormal_somatic_nervous | 0.76791036 |
| 84 | MP0005266_abnormal_metabolism | 0.75889285 |
| 85 | MP0001486_abnormal_startle_reflex | 0.75708537 |
| 86 | MP0002095_abnormal_skin_pigmentation | 0.75697169 |
| 87 | MP0005636_abnormal_mineral_homeostasis | 0.75326028 |
| 88 | MP0005391_vision/eye_phenotype | 0.74852143 |
| 89 | MP0009053_abnormal_anal_canal | 0.73455898 |
| 90 | MP0002572_abnormal_emotion/affect_behav | 0.73271639 |
| 91 | MP0005332_abnormal_amino_acid | 0.72602730 |
| 92 | MP0004043_abnormal_pH_regulation | 0.71650381 |
| 93 | MP0005389_reproductive_system_phenotype | 0.69422420 |
| 94 | MP0008875_abnormal_xenobiotic_pharmacok | 0.69404034 |
| 95 | MP0003119_abnormal_digestive_system | 0.68438241 |
| 96 | MP0004147_increased_porphyrin_level | 0.67953045 |
| 97 | MP0002177_abnormal_outer_ear | 0.67511386 |
| 98 | MP0003111_abnormal_nucleus_morphology | 0.66595732 |
| 99 | MP0003698_abnormal_male_reproductive | 0.64446859 |
| 100 | MP0002234_abnormal_pharynx_morphology | 0.63274648 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Acute necrotizing encephalopathy (HP:0006965) | 4.61718576 |
| 2 | Abnormal mitochondria in muscle tissue (HP:0008316) | 4.33255763 |
| 3 | Mitochondrial inheritance (HP:0001427) | 4.33235262 |
| 4 | Progressive macrocephaly (HP:0004481) | 4.17175296 |
| 5 | Increased hepatocellular lipid droplets (HP:0006565) | 4.08385965 |
| 6 | Increased CSF lactate (HP:0002490) | 4.08095870 |
| 7 | Lipid accumulation in hepatocytes (HP:0006561) | 3.94867253 |
| 8 | Hypothermia (HP:0002045) | 3.85662343 |
| 9 | Methylmalonic acidemia (HP:0002912) | 3.82015149 |
| 10 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 3.73667858 |
| 11 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 3.73667858 |
| 12 | Hepatic necrosis (HP:0002605) | 3.68018006 |
| 13 | Hepatocellular necrosis (HP:0001404) | 3.63265700 |
| 14 | Acute encephalopathy (HP:0006846) | 3.61086648 |
| 15 | Renal Fanconi syndrome (HP:0001994) | 3.34357834 |
| 16 | Increased intramyocellular lipid droplets (HP:0012240) | 3.12563094 |
| 17 | 3-Methylglutaconic aciduria (HP:0003535) | 3.07886769 |
| 18 | Methylmalonic aciduria (HP:0012120) | 3.05909276 |
| 19 | Increased serum pyruvate (HP:0003542) | 3.03157992 |
| 20 | Limb dystonia (HP:0002451) | 3.02988721 |
| 21 | Cerebral edema (HP:0002181) | 2.88714470 |
| 22 | Increased serum lactate (HP:0002151) | 2.88110928 |
| 23 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 2.73789504 |
| 24 | Abnormality of alanine metabolism (HP:0010916) | 2.73789504 |
| 25 | Hyperalaninemia (HP:0003348) | 2.73789504 |
| 26 | Abnormality of glycolysis (HP:0004366) | 2.64442174 |
| 27 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 2.64107618 |
| 28 | Exertional dyspnea (HP:0002875) | 2.59284881 |
| 29 | Type II lissencephaly (HP:0007260) | 2.58664002 |
| 30 | Increased muscle lipid content (HP:0009058) | 2.56950244 |
| 31 | Lactic acidosis (HP:0003128) | 2.56264709 |
| 32 | Retinal dysplasia (HP:0007973) | 2.55272787 |
| 33 | Molar tooth sign on MRI (HP:0002419) | 2.48392174 |
| 34 | Abnormality of midbrain morphology (HP:0002418) | 2.48392174 |
| 35 | Pancreatic cysts (HP:0001737) | 2.46649406 |
| 36 | Abnormality of renal resorption (HP:0011038) | 2.45644176 |
| 37 | Renal cortical cysts (HP:0000803) | 2.45427418 |
| 38 | Optic disc pallor (HP:0000543) | 2.39851620 |
| 39 | Glycosuria (HP:0003076) | 2.31763303 |
| 40 | Abnormality of urine glucose concentration (HP:0011016) | 2.31763303 |
| 41 | Abnormality of vitamin B metabolism (HP:0004340) | 2.30377348 |
| 42 | Oral leukoplakia (HP:0002745) | 2.27372670 |
| 43 | Hypoglycemic coma (HP:0001325) | 2.22260179 |
| 44 | Leukodystrophy (HP:0002415) | 2.21907402 |
| 45 | Abnormality of the labia minora (HP:0012880) | 2.20489985 |
| 46 | Medial flaring of the eyebrow (HP:0010747) | 2.20299402 |
| 47 | Pancreatic fibrosis (HP:0100732) | 2.19643679 |
| 48 | Generalized aminoaciduria (HP:0002909) | 2.17793893 |
| 49 | Microvesicular hepatic steatosis (HP:0001414) | 2.17775374 |
| 50 | Testicular atrophy (HP:0000029) | 2.17754511 |
| 51 | Respiratory failure (HP:0002878) | 2.16446663 |
| 52 | Dicarboxylic aciduria (HP:0003215) | 2.14422865 |
| 53 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.14422865 |
| 54 | Abnormality of the vitamin B12 metabolism (HP:0004341) | 2.13109545 |
| 55 | Congenital, generalized hypertrichosis (HP:0004540) | 2.13079384 |
| 56 | True hermaphroditism (HP:0010459) | 2.12337543 |
| 57 | Opisthotonus (HP:0002179) | 2.12179294 |
| 58 | Agitation (HP:0000713) | 2.09353081 |
| 59 | Exercise intolerance (HP:0003546) | 2.08680532 |
| 60 | Nephronophthisis (HP:0000090) | 2.03558182 |
| 61 | Abnormality of the renal cortex (HP:0011035) | 2.03548855 |
| 62 | Lethargy (HP:0001254) | 1.99849880 |
| 63 | Cerebellar dysplasia (HP:0007033) | 1.99743836 |
| 64 | Adrenal hypoplasia (HP:0000835) | 1.99306678 |
| 65 | Lissencephaly (HP:0001339) | 1.98390375 |
| 66 | Macrocytic anemia (HP:0001972) | 1.95724003 |
| 67 | Unsteady gait (HP:0002317) | 1.90732552 |
| 68 | Hyperglycinemia (HP:0002154) | 1.87854431 |
| 69 | Progressive inability to walk (HP:0002505) | 1.86906001 |
| 70 | Abnormal number of erythroid precursors (HP:0012131) | 1.86229887 |
| 71 | Hypoplasia of the pons (HP:0012110) | 1.85963411 |
| 72 | Hyperphosphaturia (HP:0003109) | 1.84978944 |
| 73 | Concave nail (HP:0001598) | 1.84516214 |
| 74 | Large for gestational age (HP:0001520) | 1.84041831 |
| 75 | Limb hypertonia (HP:0002509) | 1.83190794 |
| 76 | Blindness (HP:0000618) | 1.80650335 |
| 77 | Respiratory difficulties (HP:0002880) | 1.79434858 |
| 78 | Focal motor seizures (HP:0011153) | 1.79227563 |
| 79 | Hypoglycemic seizures (HP:0002173) | 1.79179492 |
| 80 | Abnormal number of incisors (HP:0011064) | 1.78316872 |
| 81 | Emotional lability (HP:0000712) | 1.78299628 |
| 82 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 1.77901940 |
| 83 | Abnormality of the pons (HP:0007361) | 1.77278062 |
| 84 | Cerebral hypomyelination (HP:0006808) | 1.74093016 |
| 85 | Hyperinsulinemic hypoglycemia (HP:0000825) | 1.73772603 |
| 86 | Abnormality of abdominal situs (HP:0011620) | 1.72802863 |
| 87 | Abdominal situs inversus (HP:0003363) | 1.72802863 |
| 88 | Muscular hypotonia of the trunk (HP:0008936) | 1.72591464 |
| 89 | Absent/shortened dynein arms (HP:0200106) | 1.69972932 |
| 90 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 1.69972932 |
| 91 | Sclerocornea (HP:0000647) | 1.69818596 |
| 92 | Poor suck (HP:0002033) | 1.69750676 |
| 93 | Abnormal respiratory motile cilium morphology (HP:0005938) | 1.68201050 |
| 94 | Abnormal respiratory epithelium morphology (HP:0012253) | 1.68201050 |
| 95 | Pendular nystagmus (HP:0012043) | 1.66658466 |
| 96 | Pachygyria (HP:0001302) | 1.66295877 |
| 97 | Brushfield spots (HP:0001088) | 1.64772391 |
| 98 | Aplasia/hypoplasia of the uterus (HP:0008684) | 1.64513212 |
| 99 | Abnormality of cells of the erythroid lineage (HP:0012130) | 1.64412899 |
| 100 | Poor head control (HP:0002421) | 1.62257387 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP4K2 | 3.52188341 |
| 2 | WNK3 | 3.38615427 |
| 3 | MAP3K4 | 2.99614027 |
| 4 | VRK2 | 2.93424101 |
| 5 | MAP2K7 | 2.90108821 |
| 6 | TLK1 | 2.72214309 |
| 7 | ZAK | 2.48876256 |
| 8 | VRK1 | 2.48508243 |
| 9 | SRPK1 | 2.37465771 |
| 10 | CDC7 | 2.34724805 |
| 11 | BCKDK | 2.18460218 |
| 12 | BUB1 | 2.00614447 |
| 13 | PINK1 | 1.96989617 |
| 14 | TSSK6 | 1.84186521 |
| 15 | CSNK1G3 | 1.77141514 |
| 16 | NEK1 | 1.76031118 |
| 17 | ADRBK2 | 1.75099414 |
| 18 | DYRK2 | 1.71803473 |
| 19 | CSNK1G2 | 1.67753954 |
| 20 | CDK8 | 1.62027428 |
| 21 | MUSK | 1.61744410 |
| 22 | PNCK | 1.60616185 |
| 23 | CSNK1A1L | 1.60326757 |
| 24 | CSNK1G1 | 1.53002605 |
| 25 | MST4 | 1.46998437 |
| 26 | MARK1 | 1.46601121 |
| 27 | BMPR1B | 1.45632695 |
| 28 | NME2 | 1.44679536 |
| 29 | EIF2AK1 | 1.40106271 |
| 30 | LIMK1 | 1.34078246 |
| 31 | ERBB3 | 1.33263899 |
| 32 | PASK | 1.22149397 |
| 33 | TAF1 | 1.20533942 |
| 34 | GRK1 | 1.19806430 |
| 35 | AURKA | 1.18504427 |
| 36 | MAPK13 | 1.18325267 |
| 37 | NUAK1 | 1.17049277 |
| 38 | WEE1 | 1.16419100 |
| 39 | PBK | 1.12617849 |
| 40 | TESK2 | 1.10747399 |
| 41 | MKNK2 | 1.04086629 |
| 42 | RPS6KA5 | 1.02720516 |
| 43 | TNIK | 1.02237117 |
| 44 | CASK | 1.00809031 |
| 45 | EIF2AK3 | 0.99644289 |
| 46 | PLK3 | 0.95757030 |
| 47 | CDK19 | 0.93568970 |
| 48 | ALK | 0.92178727 |
| 49 | STK16 | 0.91414079 |
| 50 | CHEK2 | 0.89960592 |
| 51 | RPS6KA4 | 0.88948825 |
| 52 | MAP2K4 | 0.88099266 |
| 53 | DAPK3 | 0.87749528 |
| 54 | BMPR2 | 0.85434569 |
| 55 | MAP3K12 | 0.85063491 |
| 56 | MKNK1 | 0.81608561 |
| 57 | PLK1 | 0.79969128 |
| 58 | OXSR1 | 0.77555036 |
| 59 | AURKB | 0.73732519 |
| 60 | NTRK2 | 0.71496725 |
| 61 | ATR | 0.68323113 |
| 62 | TESK1 | 0.67310551 |
| 63 | ERBB4 | 0.67308671 |
| 64 | PLK4 | 0.66149994 |
| 65 | ACVR1B | 0.64761436 |
| 66 | EIF2AK2 | 0.63500466 |
| 67 | PHKG1 | 0.56930109 |
| 68 | PHKG2 | 0.56930109 |
| 69 | ABL2 | 0.56613188 |
| 70 | CDK3 | 0.56589861 |
| 71 | CSNK2A2 | 0.55288799 |
| 72 | CLK1 | 0.54845548 |
| 73 | CCNB1 | 0.52618474 |
| 74 | PRKCI | 0.50917117 |
| 75 | CSNK1E | 0.49631389 |
| 76 | ILK | 0.49510367 |
| 77 | ADRBK1 | 0.49177861 |
| 78 | CSNK1A1 | 0.49163929 |
| 79 | TRIM28 | 0.48032683 |
| 80 | PLK2 | 0.46146200 |
| 81 | KDR | 0.45552484 |
| 82 | PRKCG | 0.44858039 |
| 83 | CSNK2A1 | 0.44726311 |
| 84 | CDK14 | 0.44276855 |
| 85 | ATM | 0.43010072 |
| 86 | TGFBR1 | 0.42286872 |
| 87 | CDK7 | 0.41286288 |
| 88 | INSRR | 0.41258786 |
| 89 | AKT2 | 0.41032253 |
| 90 | GRK5 | 0.40331307 |
| 91 | BRSK1 | 0.37432114 |
| 92 | PAK3 | 0.35606348 |
| 93 | STK11 | 0.34168979 |
| 94 | BCR | 0.33912664 |
| 95 | NME1 | 0.33537721 |
| 96 | PKN1 | 0.33001436 |
| 97 | TAOK3 | 0.32639555 |
| 98 | MINK1 | 0.32372790 |
| 99 | DAPK1 | 0.32295744 |
| 100 | IKBKB | 0.32082165 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 4.50939407 |
| 2 | Parkinsons disease_Homo sapiens_hsa05012 | 3.88756484 |
| 3 | Proteasome_Homo sapiens_hsa03050 | 3.70249480 |
| 4 | Ribosome_Homo sapiens_hsa03010 | 3.42701281 |
| 5 | Protein export_Homo sapiens_hsa03060 | 2.83429656 |
| 6 | Huntingtons disease_Homo sapiens_hsa05016 | 2.60392939 |
| 7 | Alzheimers disease_Homo sapiens_hsa05010 | 2.47284532 |
| 8 | RNA polymerase_Homo sapiens_hsa03020 | 2.43087993 |
| 9 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 2.38854123 |
| 10 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 2.30287218 |
| 11 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 2.16183318 |
| 12 | Asthma_Homo sapiens_hsa05310 | 1.96610907 |
| 13 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.94238775 |
| 14 | Spliceosome_Homo sapiens_hsa03040 | 1.87868684 |
| 15 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.82939677 |
| 16 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.77107532 |
| 17 | Basal transcription factors_Homo sapiens_hsa03022 | 1.72634568 |
| 18 | RNA degradation_Homo sapiens_hsa03018 | 1.65624414 |
| 19 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.62330903 |
| 20 | DNA replication_Homo sapiens_hsa03030 | 1.62129751 |
| 21 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.54354154 |
| 22 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.53759472 |
| 23 | Alcoholism_Homo sapiens_hsa05034 | 1.52740119 |
| 24 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.50584904 |
| 25 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 1.39940173 |
| 26 | RNA transport_Homo sapiens_hsa03013 | 1.38928854 |
| 27 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 1.38679133 |
| 28 | Nicotine addiction_Homo sapiens_hsa05033 | 1.28924552 |
| 29 | Allograft rejection_Homo sapiens_hsa05330 | 1.28122448 |
| 30 | Base excision repair_Homo sapiens_hsa03410 | 1.27179967 |
| 31 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.24526894 |
| 32 | Mismatch repair_Homo sapiens_hsa03430 | 1.24422452 |
| 33 | Homologous recombination_Homo sapiens_hsa03440 | 1.23762176 |
| 34 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.21533333 |
| 35 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.20226982 |
| 36 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 1.18997625 |
| 37 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.18288325 |
| 38 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.15101254 |
| 39 | Nucleotide excision repair_Homo sapiens_hsa03420 | 1.12785070 |
| 40 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.12567732 |
| 41 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.11672030 |
| 42 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.11494471 |
| 43 | Sulfur relay system_Homo sapiens_hsa04122 | 1.10660614 |
| 44 | Purine metabolism_Homo sapiens_hsa00230 | 1.08798157 |
| 45 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.01689860 |
| 46 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.99126689 |
| 47 | Peroxisome_Homo sapiens_hsa04146 | 0.98591385 |
| 48 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.97212141 |
| 49 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.95662304 |
| 50 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.93226388 |
| 51 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.90251513 |
| 52 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.82134637 |
| 53 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.79328502 |
| 54 | Phototransduction_Homo sapiens_hsa04744 | 0.78173553 |
| 55 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.77690252 |
| 56 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.74068437 |
| 57 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.73765667 |
| 58 | Metabolic pathways_Homo sapiens_hsa01100 | 0.69621359 |
| 59 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.68213257 |
| 60 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.67935698 |
| 61 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.59618842 |
| 62 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.58433912 |
| 63 | Cell cycle_Homo sapiens_hsa04110 | 0.58423719 |
| 64 | Viral myocarditis_Homo sapiens_hsa05416 | 0.58389683 |
| 65 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.56609164 |
| 66 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.55840963 |
| 67 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.55506675 |
| 68 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.55306246 |
| 69 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.54846508 |
| 70 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.52113138 |
| 71 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.50764360 |
| 72 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.47953773 |
| 73 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.47149534 |
| 74 | Olfactory transduction_Homo sapiens_hsa04740 | 0.43357275 |
| 75 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.42815979 |
| 76 | Cocaine addiction_Homo sapiens_hsa05030 | 0.41293095 |
| 77 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.39212261 |
| 78 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.37974726 |
| 79 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.36742971 |
| 80 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.35279391 |
| 81 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.33739542 |
| 82 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.33310514 |
| 83 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.32620037 |
| 84 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.31633525 |
| 85 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.31236016 |
| 86 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.31145829 |
| 87 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.30175955 |
| 88 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.29807558 |
| 89 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.25253197 |
| 90 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.25131388 |
| 91 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.21974729 |
| 92 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.21302116 |
| 93 | Morphine addiction_Homo sapiens_hsa05032 | 0.20750846 |
| 94 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.20331980 |
| 95 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.20164547 |
| 96 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.20085358 |
| 97 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.19550499 |
| 98 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.19086566 |
| 99 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.18192978 |
| 100 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.17814004 |

